Function and Scar in Trigger Finger Release
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05477290 |
Recruitment Status :
Recruiting
First Posted : July 28, 2022
Last Update Posted : March 31, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Trigger Finger | Procedure: Trigger Finger Release through Transverse Incision Procedure: Trigger Finger Release through Oblique Incision Procedure: Trigger Finger Release through Vertical Incision |
A study describing the superior incision technique is still needed to assess post-open release outcomes of the surgical site such as aesthetics and hand function. This study contributes to literature by providing further clarification into which technique of open trigger finger release is preferential to optimize scar aesthetics, increase function and, minimize complications using patient reported outcome measures such as the MHQ and SCAR-Q. The primary objective of this study is to assess patient Health-Related Quality of Life related to hand function via three incisional techniques using the generic hand instrument, (MHQ). This will be measured at 1 week prior, 1 day prior, and 1, 3, and 6 months post operation. The secondary objective will be to evaluate the Health-Related Quality of Life related to scar appearance post trigger finger release of three (transverse, oblique and vertical) incisional techniques of trigger finger release using the SCAR-Q (a condition-specific scales) at 1, 3 and 6 months post operation.
This study will be employed as a three-arm prospective cohort study. Local surgeons practicing at St. Joseph's Healthcare who utilize different incisional techniques for trigger finger release will compare each of their techniques. As each group sees trigger finger at a roughly equal rate, it is expected that the target of 30 patients in each group will be met in a similar timeline. Data will be recorded by a research team member that is not the operating physician via a paper-based system specific to this study.
At consultation patients will be approached for consent within a private consultation room within the surgical clinic. One week prior to surgery patients will complete questionnaires at the principle investigator's office (completed by the RA) in a private room. Post operation, patients will return to the principle investigator's office at 1, 3, 6 and 12 months post operation to complete the same questionnaires and to document any complications they have experienced.
Study Type : | Observational |
Estimated Enrollment : | 90 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | A Comparative Study of Hand Function and Scar-Related Health-Related Quality of Life in Trigger Finger Release |
Actual Study Start Date : | June 10, 2019 |
Estimated Primary Completion Date : | December 2023 |
Estimated Study Completion Date : | December 2024 |
Group/Cohort | Intervention/treatment |
---|---|
Transverse incision
At the level of the A1 pulley, a transverse incision will be made and the flexor pulley will be exposed with blunt dissection. The pulley will be transected and the wound will subsequently be closed with 4.0 Monocryl after ensuring complete release
|
Procedure: Trigger Finger Release through Transverse Incision
At the level of the A1 pulley, a transverse incision will be made and the flexor pulley will be exposed with blunt dissection. The pulley will be transected and the wound will subsequently be closed with 4.0 Monocryl after ensuring complete release. |
Oblique incision
At the level of the A1 pulley, a oblique incision will be made and the flexor pulley will be exposed with blunt dissection. The pulley will be transected and the wound will subsequently be closed with 4.0 Monocryl after ensuring complete release.
|
Procedure: Trigger Finger Release through Oblique Incision
At the level of the A1 pulley, a oblique incision will be made and the flexor pulley will be exposed with blunt dissection. The pulley will be transected and the wound will subsequently be closed with 4.0 Monocryl after ensuring complete release. |
Vertical incision
At the level of the A1 pulley, a vertical incision will be made and the flexor pulley will be exposed with blunt dissection. The pulley will be transected and the wound will subsequently be closed with 4.0 Monocryl after ensuring complete release.
|
Procedure: Trigger Finger Release through Vertical Incision
At the level of the A1 pulley, a vertical incision will be made and the flexor pulley will be exposed with blunt dissection. The pulley will be transected and the wound will subsequently be closed with 4.0 Monocryl after ensuring complete release. |
- Change in Health-Related Quality of Life related to hand function [ Time Frame: 1 week prior, 1 day prior, and 1, 3 and 12 months post operation ]Outcome measured through the Michigan Hand Questionnaire (MHQ). The MHQ has a total score of 100; the lowest possible score is 0. A score of 100 on the MHQ indicates the best possible ability.
- Change in Health-Related Quality of Life related to scar appearance [ Time Frame: 1 week prior, 1 day prior, and 1, 3 and 12 months post operation ]Scar appearance, symptoms and the psychosocial impact of the scar will be measured using the SCAR-Q. This questionnaire has a minimum score of 0 and a maximum score of 100 with higher scores indicating a better outcome.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 18 years of age or older
- Trigger finger release of the 2nd, 3rd, 4th, or 5th finger
- Diagnosed stenosing tenosynovitis or trigger finger prior to release
- Able to understand and communicate English
Exclusion Criteria:
- Previous attempted surgical treatment
- Patients undergoing any concomitant procedure on the same hand (e.g. carpal tunnel release)
- Patients who are unable to provide informed consent.
- Patients who do not have a fixed address
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05477290
Contact: Achilles Thoma, MD | (905) 523-0019 | athoma@mcmaster.ca |
Canada, Ontario | |
St. Joseph's Healthcare | Recruiting |
Hamilton, Ontario, Canada, L8N 4A6 | |
Contact: Achilles Thoma, MD 905-523-0019 drathoma@cogeco.net |
Principal Investigator: | Achilles Thoma, MD | McMaster University |
Responsible Party: | Achilleas Thoma, Surgeon, McMaster University |
ClinicalTrials.gov Identifier: | NCT05477290 |
Other Study ID Numbers: |
7242 |
First Posted: | July 28, 2022 Key Record Dates |
Last Update Posted: | March 31, 2023 |
Last Verified: | March 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | we do not plan on sharing data with other researchers |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Scar Function Health-Related Quality of Life |
Trigger Finger Disorder Tendon Entrapment Tendinopathy Muscular Diseases Musculoskeletal Diseases |